Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2016 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2017-02-10

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 10, 2017

Total Value: $168M (89.7% shares, 10.3% debt)

Holdings (23)

— Recro Pharma, Inc. 13.8%

Value $23.17M Shares 2,874,317 Share Price $8.06 Est. Cost/Share $8.20 Unrealized @ Report Date —

— Aegerion Pharmaceuticals, Inc. 10.3%

Value $17.24M Shares 24,200,000 Share Price $0.71 Est. Cost/Share $0.60 Unrealized @ Report Date —

— Alere Inc. 8.4%

Value $14.03M Shares 360,000 Share Price $38.97 Est. Cost/Share $42.05 Unrealized @ Report Date —

— Sciclone Pharmaceuticals, Inc. 8.0%

Value $13.49M Shares 1,249,200 Share Price $10.80 Est. Cost/Share $10.80 Unrealized @ Report Date —

— Viveve Medical, Inc 7.9%

Value $13.3M Shares 2,599,711 Share Price $5.11 Est. Cost/Share $7.22 Unrealized @ Report Date —

— Novelion Therapeutics, Inc. 7.6%

Value $12.83M Shares 1,524,034 Share Price $8.42 Est. Cost/Share $8.42 Unrealized @ Report Date —

— Ophthotech Corp 6.6%

Value $11.07M Shares 2,292,900 Share Price $4.83 Est. Cost/Share $4.83 Unrealized @ Report Date —

— Cardiome Pharma Corp 5.2%

Value $8.718M Shares 3,158,816 Share Price $2.76 Est. Cost/Share $2.98 Unrealized @ Report Date —

ENTA Enanta Pharmaceuticals 4.6%

Value $7.769M Shares 231,913 Share Price $33.50 * Est. Cost/Share $28.66 Unrealized @ Report Date 0.0%

VCYT Veracyte, Inc. 4.5%

Value $7.512M Shares 970,500 Share Price $7.74 * Est. Cost/Share $7.48 Unrealized @ Report Date 0.0%

VCEL Vericel Corp 3.4%

Value $5.651M Shares 1,883,800 Share Price $3.00 * Est. Cost/Share $2.52 Unrealized @ Report Date +1.9%

— Alimera Sciences, Inc 3.0%

Value $4.985M Shares 4,615,813 Share Price $1.08 Est. Cost/Share $1.25 Unrealized @ Report Date —

— Biodelivery Sciences INTL 2.7%

Value $4.551M Shares 2,600,711 Share Price $1.75 Est. Cost/Share $1.75 Unrealized @ Report Date —

— Sucampo Pharmaceuticals - CL A 2.3%

Value $3.848M Shares 284,002 Share Price $13.55 Est. Cost/Share $13.55 Unrealized @ Report Date —

CPIX Cumberland Pharmaceuticals, Inc. 2.0%

Value $3.407M Shares 619,538 Share Price $5.50 * Est. Cost/Share $4.92 Unrealized @ Report Date +6.0%

— Flamel Technologies - SP ADR 2.0%

Value $3.388M Shares 326,087 Share Price $10.39 Est. Cost/Share $10.39 Unrealized @ Report Date —

— Trinity Biotech PLC - SPON ADR 1.8%

Value $3.018M Shares 436,066 Share Price $6.92 Est. Cost/Share $6.92 Unrealized @ Report Date —

— Durect Corporation 1.7%

Value $2.918M Shares 2,177,791 Share Price $1.34 Est. Cost/Share $1.37 Unrealized @ Report Date —

— Mallinckrodt PLC 1.3%

Value $2.174M Shares 43,629 Share Price $49.83 Est. Cost/Share $49.83 Unrealized @ Report Date —

— Cutera, Inc. 1.2%

Value $2.089M Shares 120,429 Share Price $17.35 Est. Cost/Share $11.59 Unrealized @ Report Date —

— Juniper Pharmaceuticals, Inc. 0.8%

Value $1.279M Shares 228,392 Share Price $5.60 Est. Cost/Share $5.56 Unrealized @ Report Date —

— CTI Biopharma Corp 0.6%

Value $1.067M Shares 2,617,136 Share Price $0.41 Est. Cost/Share $0.41 Unrealized @ Report Date —

— Aviragen Therapeutics, Inc. 0.2%

Value $380K Shares 309,278 Share Price $1.23 Est. Cost/Share $1.48 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	Recro Pharma, Inc.	2,874,317	$23.17M	13.8%	$8.06	$8.20	—	COM	75629F109
—	Aegerion Pharmaceuticals, Inc.	24,200,000	$17.24M	10.3%	$0.71	$0.60	—	NOTE	00767EAB8
—	Alere Inc.	360,000	$14.03M	8.4%	$38.97	$42.05	—	COM	01449J105
—	Sciclone Pharmaceuticals, Inc.	1,249,200	$13.49M	8.0%	$10.80	$10.80	—	COM	80862K104
—	Viveve Medical, Inc	2,599,711	$13.3M	7.9%	$5.11	$7.22	—	COM	92852W204
—	Novelion Therapeutics, Inc.	1,524,034	$12.83M	7.6%	$8.42	$8.42	—	COM	67001K202
—	Ophthotech Corp	2,292,900	$11.07M	6.6%	$4.83	$4.83	—	COM	683745103
—	Cardiome Pharma Corp	3,158,816	$8.718M	5.2%	$2.76	$2.98	—	COM	14159U301
ENTA	Enanta Pharmaceuticals	231,913	$7.769M	4.6%	$33.50 *	$28.66	0.0%	COM	29251M106
VCYT	Veracyte, Inc.	970,500	$7.512M	4.5%	$7.74 *	$7.48	0.0%	COM	92337F107
VCEL	Vericel Corp	1,883,800	$5.651M	3.4%	$3.00 *	$2.52	+1.9%	COM	92346J108
—	Alimera Sciences, Inc	4,615,813	$4.985M	3.0%	$1.08	$1.25	—	COM	016259103
—	Biodelivery Sciences INTL	2,600,711	$4.551M	2.7%	$1.75	$1.75	—	COM	09060J106
—	Sucampo Pharmaceuticals - CL A	284,002	$3.848M	2.3%	$13.55	$13.55	—	COM	864909106
CPIX	Cumberland Pharmaceuticals, Inc.	619,538	$3.407M	2.0%	$5.50 *	$4.92	+6.0%	COM	230770109
—	Flamel Technologies - SP ADR	326,087	$3.388M	2.0%	$10.39	$10.39	—	SPONS ADR	338488109
—	Trinity Biotech PLC - SPON ADR	436,066	$3.018M	1.8%	$6.92	$6.92	—	SPONS ADR	896438306
—	Durect Corporation	2,177,791	$2.918M	1.7%	$1.34	$1.37	—	COM	266605104
—	Mallinckrodt PLC	43,629	$2.174M	1.3%	$49.83	$49.83	—	SHS	G5785G107
—	Cutera, Inc.	120,429	$2.089M	1.2%	$17.35	$11.59	—	COM	232109108
—	Juniper Pharmaceuticals, Inc.	228,392	$1.279M	0.8%	$5.60	$5.56	—	COM	48203L107
—	CTI Biopharma Corp	2,617,136	$1.067M	0.6%	$0.41	$0.41	—	COM	12648L106
—	Aviragen Therapeutics, Inc.	309,278	$380K	0.2%	$1.23	$1.48	—	COM	053761102